<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-4CJC9ZRN</identifier><date>2013</date><creator>Bavec, Aljoša</creator><creator>Deželak, Matjaž</creator><relation>documents/doc/4/URN_NBN_SI_doc-4CJC9ZRN_001.htm</relation><relation>documents/doc/4/URN_NBN_SI_doc-4CJC9ZRN_001.pdf</relation><relation>documents/doc/4/URN_NBN_SI_doc-4CJC9ZRN_001.txt</relation><format format_type="issue">3</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 211-217</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">30773721</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-4CJC9ZRN</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">debelost</subject><subject language_type_id="eng">obesity</subject><subject language_type_id="eng">peptide drugs</subject><subject language_type_id="slv">peptidne učinkovine</subject><subject language_type_id="slv">sladkorna bolezen tipa 2</subject><subject language_type_id="eng">type 2 diabetes mellitus</subject><title>Glucagon like peptide-1 receptor agonists and their application in treatment of diabetes mellitus type 2 and obesity</title><title>Peptidni agonisti receptorja za glukagonu podobni peptid-1 ter njihova uporaba pri zdravljenju sladkorne bolezni tipa 2 in debelosti</title></Record>